Factors associated with red blood cell transfusion among hospitalized patients: a cross-sectional study  

作　　者：Peiwen ZHANG Dandan XU Xinhan ZHANG Mengyin WU Xuecheng YAO Dawei CUI Jue XIE 

机构地区：[1]Department of Blood Transfusion,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China [2]Department of Epidemiology and Biostatistics,Zhejiang University School of Public Health,Hangzhou 310058,China

出　　处：《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》2021年第12期1060-1064,共5页浙江大学学报（英文版）B辑（生物医学与生物技术）

基　　金：supported by the National Natural Science Foundation of China(Nos.91846103 and 81971994);the Zhejiang Provincial Key Research and Development Program(No.2020C03032),China。

摘　　要：Red blood cell(RBC)transfusion is a clinically effective therapy in anemia,for example in patients with malignancies(Shander et al.,2020),bleeding(Odutayo et al.,2017),and preoperative anemia(Pad-manabhan et al.,2019).The past few decades have witnessed a shortage of blood for transfusion due to limited health insurance coverage for blood use and the rapid expansion of hospitals(Chen et al.,2011;Shi et al.,2014).Blood donation levels may easily be affected by general changes in the environment,policy,major events such as disasters,and public sentiment(Hu et al.,2019).

关 键 词：TRANSFUSION PATIENTS 

分 类 号：R457.1[医药卫生—治疗学]